GSTA Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of GSTA Antibodies for investigating glutathione S-transferases (GSTs) in cellular processes. GSTA monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Glutathione S-transferases are essential enzymes that facilitate the detoxification of harmful compounds, including drugs and environmental toxins, by catalyzing the conjugation of glutathione to various substrates. GST enzymes serve as key components in cellular defense mechanisms and have been linked to numerous diseases, including cancer and neurodegenerative disorders. Research focused on GSTA has revealed significant insights into cellular detoxification pathways and their impact on disease progression. Understanding glutathione S-transferase function and regulation continues to advance knowledge in both basic research and clinical applications. Investigating GSTA expression patterns helps identify potential therapeutic targets and biomarkers for various pathological conditions. GSTA research using Santa Cruz Biotechnology monoclonal antibodies contributes to advancing scientific understanding of cellular defense mechanisms and disease treatments.